• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Fentanyl Testing: An Emerging Harm Reduction Strategy
Clinical Update

Fentanyl Testing: An Emerging Harm Reduction Strategy

May 29, 2023
Noah Capurso, MD and Alyssa Falleni, PharmD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Alyssa Falleni, PharmD. CT Health Education and Research in SUD and Related Harms (CHERISH) Fellow; VA Connecticut Healthcare System, Orange, CT.

Noah Capurso, MD, MHS. Assistant Professor of Psychiatry, Yale University, New Haven, CT; Editor-in-Chief of The Carlat Addiction Treatment Report.

Dr. Falleni and Dr. Capurso have no financial relationships with companies related to this material.

The epidemic of opioid overdose deaths has continued to worsen, driven in large part by the recent rise in fentanyl availability. This potent synthetic opioid is being increasingly found in illicit drugs, often without a user’s knowledge. Drug testing with fentanyl test strips (FTS) informs people as to whether a drug they have purchased contains fentanyl, allowing them the choice to discard the drug or use it more safely. In this article, we review the technology behind FTS, how they can be obtained, how to properly use them, how to discuss them with patients, and their legality.

How FTS work

Originally developed to test for the presence of fentanyl in urine, FTS can also detect the presence of fentanyl in drugs obtained illicitly from the street (Krieger MS et al, Int J Drug Policy 2018;61:52–58). The strips use immunoassay technology, which is also found in urine drug screens and over-the-counter pregnancy tests. In an immunoassay, drug detection relies on binding between an antibody and the drug of interest or its metabolite (see CATR May/June 2022 to learn more about urine drug screens and immunoassay).

Benefits of immunoassay technology include its low cost, ease of use, and quick turnaround time. More specifically, FTS are reasonably accurate, with one study showing overall sensitivity and specificity of 98.5% and 89.2%, respectively, in the popular FTS brand BTNX Rapid Response (Park JN et al, Drug Alcohol Depend 2022;240:109610). The main limitation for FTS is that they can only detect fentanyl in the portion of drug that is being tested. Fentanyl can be unevenly distributed throughout a pill or a powder, and test results can therefore be inconsistent. The greater portion of drug that is tested, the more reliable results will be.

Who should use FTS

With fentanyl finding its way into more and more drug markets, anyone using drugs that do not come directly from a pharmacy should consider drug testing. Illicit opioids like heroin tend to contain fentanyl more often than not. Testing these drugs can be useful because a positive test can serve as a warning to not use the drug at all, to go “low and slow” (small doses administered slowly), or to only use the drug if others are around.

Some pills sold on the streets as prescription pills are in fact sophisticated counterfeits that contain fentanyl. These “pressed pills” can be indistinguishable from the real thing, so encourage patients to test them for fentanyl, even if they look like they came from a pharmacy.

In recent years, fentanyl has begun to show up in non-opioid drugs as well, including stimulants like cocaine and methamphetamines, hallucinogens like MDMA (ecstasy/molly), and even cannabis products. Anyone using these non-opioid drugs should especially be encouraged to test them for fentanyl, since these are people who usually do not have opioid tolerance.

Accessing FTS

FTS do not require a prescription. Most needle exchange programs and organizations that distribute naloxone will provide FTS free of charge. FTS can also be purchased through many online retail outlets. Costs vary, but FTS are typically around $2 per strip. To locate FTS suppliers in your area as well as online retailers, see the “Fentanyl Test Strip Resources” table.

Table. Fentanyl Test Strip Resources
Click to view a PDF

How to use FTS

FTS are easy to use and do not require a high degree of health literacy. Instruct patients on the following three-step process:

  1. Select sample to test—there are three options to choose from:
    • Dissolve all your drugs in water. This is the most accurate option. Drugs can still be used by drinking the solution, snorting it using a nasal sprayer, or waiting for the water to evaporate.
    • Crush drugs on a clean surface. Add the powder to a small plastic bag. Shake the bag to mix up the powder and dump it out. The residue left inside the bag can be tested.
    • Put 10 mg or more of drugs in a dry container like a bottle cap, small drinking glass, or clean cooker. Ten milligrams of powder is enough to cover the hair of Abraham Lincoln on a penny.
  2. Dissolve the drugs in water. For methamphetamine and MDMA, use one teaspoon for every 10 mg. For all other drugs, use half a teaspoon.
  3. Place the wavy end of the FTS into the water. Allow the FTS to absorb the solution for about 15 seconds. Pull the FTS out, place it on a flat surface, and wait for two to five minutes. (Think “wavy, water, wait.”)

A single pink line toward the portion of the FTS that is held indicates the presence of fentanyl. Two pink lines means that fentanyl was not detected, though patients should be instructed to always proceed with caution since no test is 100% accurate. The absence of lines, or a single pink line toward the wavy part of the FTS, indicates an invalid test, in which case the drugs should be retested with a new FTS (see “How to Read a Fentanyl Test Strip”).

Regulations

FTS laws can be complex and confusing. Some states outlaw any equipment used to test controlled substances, including FTS, defining them as drug paraphernalia. Other states have specific carve-outs that allow FTS. Still others have a definition of drug paraphernalia that does not include drug testing equipment, making FTS de facto legal to possess. Many states are in the process of passing carve-out legislation that would allow FTS under certain circumstances. The laws are constantly changing, so we recommend contacting your local public health departments to stay up to date.

CARLAT VERDICT

Testing drugs for fentanyl with FTS can be a lifesaving method of harm reduction. Inform all your patients using illicit drugs of its importance, ensure they have access to FTS, and instruct them on proper use. Be aware that FTS legislation is rapidly evolving, so familiarize your- self with local regulations.       

CATR_JulAugSep2023_TableP5_FentanylTest.pngTable. How to Read a Fentanyl Test Strip
Click to view a PDF


Addiction Treatment Clinical Update
KEYWORDS harm reduction
    Qa1 noah capurso headshot 150x150
    Noah Capurso, MD

    Stimulant Update with Dr. Brian Hurley

    More from this author
    Alyssa Falleni, PharmD

    More from this author
    www.thecarlatreport.com
    Issue Date: May 29, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Revisiting Opioid Use Disorder, CATR, Jul/Aug/Sept 2023
    Fentanyl Testing: An Emerging Harm Reduction Strategy
    The State of Opioids on the Street
    Starting Medication for Opioid Use Disorder
    What Psychiatrists Need to Know About Intravenous Drug Use and Endocarditis
    Intravenous Buprenorphine Microinduction
    CME Post-Test, Revisiting Opioid Use Disorder, CATR, Jul/Aug/Sept 2023
    DOWNLOAD NOW
    Featured Book
    • OUDFB1e_Cover_Binding.png

      Treating Opioid Use Disorder—A Fact Book (2024)

      All the tools you need to assess and treat patients struggling with opioid use disorder. 
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.